Skip to main content
. Author manuscript; available in PMC: 2020 Feb 14.
Published in final edited form as: Leukemia. 2010 Apr 22;24(6):1121–1127. doi: 10.1038/leu.2010.60

Figure 1.

Figure 1

Risk stratification for smoldering multiple myeloma. The model incorporates three risk factors: abnormal FLC ratio, bone marrow plasma cells ⩾10% and serum M protein ⩾3 g/dl. Patients with 1, 2 or 3 risk factors had 5-year progression rates of 25, 51 and 76%, respectively. Corresponding median times to progression are 10, 5.1 and 1.9 years, respectively.